Transcription Factor FOXA1 Facilitates Glycolysis and Proliferation of Lung Adenocarcinoma via Activation of TEX19.
FOXA1
Glycolysis
LUAD
Proliferation
TEX19
Journal
Molecular biotechnology
ISSN: 1559-0305
Titre abrégé: Mol Biotechnol
Pays: Switzerland
ID NLM: 9423533
Informations de publication
Date de publication:
22 Aug 2023
22 Aug 2023
Historique:
received:
23
02
2023
accepted:
02
08
2023
medline:
22
8
2023
pubmed:
22
8
2023
entrez:
22
8
2023
Statut:
aheadofprint
Résumé
Glycolysis is a shared feature in various cancers including lung adenocarcinoma (LUAD). Testis Expressed 19 (TEX19) is correlated with cancer progression. But its effect on LUAD remains an unanswered question. The focus of our study was primarily to investigate how TEX19 works exactly in LUAD. We first downloaded mRNA data from TCGA-LUAD and performed differential expression analysis. Then, we performed a Kaplan-Meier analysis to analyze the relationship between mRNA expression and patients' prognoses. hTFtarget database was utilized for the prediction of upstream transcription factors of mRNA. Next, qRT-PCR was employed for detecting TEX19 and Forkhead box A1 (FOXA1) expression. Western blot was adopted to detect the expression of glycolysis-related proteins. We also used CCK-8, colony formation, and flow cytometry assays to detect cell viability, proliferation, and apoptosis. Seahorse XF Extracellular Flux Analyzers were introduced to analyze extracellular acidification rate (ECAR) and oxygen consumption rate (OCR). Detection kits were used to detect pyruvate, lactate, citric acid, and malic acid. TEX19 was highly expressed in LUAD tissues. Real-time quantitative PCR (qRT-PCR) assay showed that TEX19 was significantly overexpressed in LUAD cell lines compared with normal bronchial epithelial cells BEAS-2B. Knockdown of TEX19 remarkably inhibited cell activity and proliferation, and promoted cell apoptosis, TEX19 was enriched in the glycolytic pathway. Meanwhile, the knockdown of TEX19 significantly hampered the contents of pyruvate, lactate, citric acid, and malic acid. The bioinformatics analysis, dual luciferase reporter experiment, and chromatin immunoprecipitation (ChIP) assay showed that FOXA1 was bound with TEX19. FOXA1 had a high expression level in LUAD. The rescue assay demonstrated that FOXA1, by activating TEX19 expression, enhanced glycolysis and proliferation and inhibited apoptosis of LUAD cells. In summary, FOXA1 promoted glycolysis and proliferation of LUAD cells by activating TEX19. This result can provide a theoretical basis for future research on LUAD.
Identifiants
pubmed: 37606876
doi: 10.1007/s12033-023-00848-2
pii: 10.1007/s12033-023-00848-2
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Sung, H., et al. (2021). Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71, 209–249. https://doi.org/10.3322/caac.21660
doi: 10.3322/caac.21660
pubmed: 33538338
Li, Y., et al. (2021). RNA m(6)A reader YTHDF2 facilitates lung adenocarcinoma cell proliferation and metastasis by targeting the AXIN1/Wnt/beta-catenin signaling. Cell Death and Disease, 12, 479. https://doi.org/10.1038/s41419-021-03763-z
doi: 10.1038/s41419-021-03763-z
pubmed: 33980824
pmcid: 8116339
Liu, X. S., et al. (2021). NPM1 is a prognostic biomarker involved in immune infiltration of lung adenocarcinoma and associated with m6A modification and glycolysis. Frontiers in Immunology, 12, 724741. https://doi.org/10.3389/fimmu.2021.724741
doi: 10.3389/fimmu.2021.724741
pubmed: 34335635
pmcid: 8324208
Nooreldeen, R., & Bach, H. (2021). Current and future development in lung cancer diagnosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms22168661
doi: 10.3390/ijms22168661
pubmed: 34445366
pmcid: 8395394
Duma, N., Santana-Davila, R., & Molina, J. R. (2019). Non-small cell lung cancer: Epidemiology, screening, diagnosis, and treatment. Mayo Clinic Proceedings, 94, 1623–1640. https://doi.org/10.1016/j.mayocp.2019.01.013
doi: 10.1016/j.mayocp.2019.01.013
pubmed: 31378236
Park, J. H., Pyun, W. Y., & Park, H. W. (2020). Cancer metabolism: Phenotype, signaling and therapeutic targets. Cells. https://doi.org/10.3390/cells9102308
doi: 10.3390/cells9102308
pubmed: 33396475
pmcid: 7824274
Li, X. B., Gu, J. D., & Zhou, Q. H. (2015). Review of aerobic glycolysis and its key enzymes—New targets for lung cancer therapy. Thoracic Cancer, 6, 17–24. https://doi.org/10.1111/1759-7714.12148
doi: 10.1111/1759-7714.12148
pubmed: 26273330
pmcid: 4448463
Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: The next generation. Cell, 144, 646–674. https://doi.org/10.1016/j.cell.2011.02.013
doi: 10.1016/j.cell.2011.02.013
pubmed: 21376230
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009). Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science (New York, NY), 324, 1029–1033. https://doi.org/10.1126/science.1160809
doi: 10.1126/science.1160809
Zhao, S., et al. (2021). LncRNA MIR17HG promotes colorectal cancer liver metastasis by mediating a glycolysis-associated positive feedback circuit. Oncogene, 40, 4709–4724. https://doi.org/10.1038/s41388-021-01859-6
doi: 10.1038/s41388-021-01859-6
pubmed: 34145399
pmcid: 8282501
Li, M., et al. (2021). RSL3 enhances the antitumor effect of cisplatin on prostate cancer cells via causing glycolysis dysfunction. Biochemical Pharmacology, 192, 114741. https://doi.org/10.1016/j.bcp.2021.114741
doi: 10.1016/j.bcp.2021.114741
pubmed: 34428443
Hu, Y., Mu, H., & Deng, Z. (2021). The transcription factor TEAD4 enhances lung adenocarcinoma progression through enhancing PKM2 mediated glycolysis. Cell Biology International, 45, 2063–2073. https://doi.org/10.1002/cbin.11654
doi: 10.1002/cbin.11654
pubmed: 34196069
Kim, J. H., et al. (2018). Enhanced glycolysis supports cell survival in EGFR-mutant lung adenocarcinoma by inhibiting autophagy-mediated EGFR degradation. Cancer Research, 78, 4482–4496. https://doi.org/10.1158/0008-5472.CAN-18-0117
doi: 10.1158/0008-5472.CAN-18-0117
pubmed: 29945964
Planells-Palop, V., et al. (2017). Human germ/stem cell-specific gene TEX19 influences cancer cell proliferation and cancer prognosis. Molecular Cancer, 16, 84. https://doi.org/10.1186/s12943-017-0653-4
doi: 10.1186/s12943-017-0653-4
pubmed: 28446200
pmcid: 5406905
Xu, Z., et al. (2020). TEX19 promotes ovarian carcinoma progression and is a potential target for epitope vaccine immunotherapy. Life Science, 241, 117171. https://doi.org/10.1016/j.lfs.2019.117171
doi: 10.1016/j.lfs.2019.117171
Blum, A., Wang, P., & Zenklusen, J. C. (2018). SnapShot: TCGA-analyzed tumors. Cell, 173, 530. https://doi.org/10.1016/j.cell.2018.03.059
doi: 10.1016/j.cell.2018.03.059
pubmed: 29625059
Huang, et al. (2022). Cancer-cell-derived GABA promotes beta-catenin-mediated tumour growth and immunosuppression. Nature Cell Biology, 24, 230–241. https://doi.org/10.1038/s41556-021-00820-9
doi: 10.1038/s41556-021-00820-9
pubmed: 35145222
pmcid: 8852304
Zhang, Y., Wang, F., Chen, G., He, R., & Yang, L. (2019). LncRNA MALAT1 promotes osteoarthritis by modulating miR-150-5p/AKT3 axis. Cell and Bioscience, 9, 54. https://doi.org/10.1186/s13578-019-0302-2
doi: 10.1186/s13578-019-0302-2
pubmed: 31304004
pmcid: 6600894
Hu, Q., et al. (2019). UHRF1 promotes aerobic glycolysis and proliferation via suppression of SIRT4 in pancreatic cancer. Cancer Letters, 452, 226–236. https://doi.org/10.1016/j.canlet.2019.03.024
doi: 10.1016/j.canlet.2019.03.024
pubmed: 30905812
Tang, Y., et al. (2018). Overexpression of PCK1 gene antagonizes hepatocellular carcinoma through the activation of gluconeogenesis and suppression of glycolysis pathways. Cellular Physiology and Biochemistry, 47, 344–355. https://doi.org/10.1159/000489811
doi: 10.1159/000489811
pubmed: 29768256
Zhou, J., et al. (2019). CircRNA-ENO1 promoted glycolysis and tumor progression in lung adenocarcinoma through upregulating its host gene ENO1. Cell Death and Disease, 10, 885. https://doi.org/10.1038/s41419-019-2127-7
doi: 10.1038/s41419-019-2127-7
pubmed: 31767835
pmcid: 6877563
Zhao, X., Wu, X., Wang, H., Yu, H., & Wang, J. (2020). USP53 promotes apoptosis and inhibits glycolysis in lung adenocarcinoma through FKBP51-AKT1 signaling. Molecular Carcinogenesis, 59, 1000–1011. https://doi.org/10.1002/mc.23230
doi: 10.1002/mc.23230
pubmed: 32511815
Zhao, P., Zhou, M., Chen, R., & Su, R. (2020). Suppressed, “Warburg effect” in nasopharyngeal carcinoma via the inhibition of pyruvate kinase type M2-mediated energy generation pathway. Technology in Cancer Research and Treatment, 19, 1533033820945804. https://doi.org/10.1177/1533033820945804
doi: 10.1177/1533033820945804
pubmed: 32815467
pmcid: 7444150
Cai, X., et al. (2017). Expression of HMGB2 indicates worse survival of patients and is required for the maintenance of Warburg effect in pancreatic cancer. Acta Biochimica et Biophysica Sinica (Shanghai), 49, 119–127. https://doi.org/10.1093/abbs/gmw124
doi: 10.1093/abbs/gmw124
Liang, Y., et al. (2020). Corrigendum to “A novel long non-coding RNA LINC00355 promotes proliferation of lung adenocarcinoma cells by down-regulating miR-195 and up-regulating the expression of CCNE1” [Cell Signal 66:109462 (2020 Feb). https://doi.org/10.1016/j.cellsig.2019.109462 ]. Cellular Signalling, 73, 10975. https://doi.org/10.1016/j.cellsig.2020.109715
doi: 10.1016/j.cellsig.2020.109715
Yu, Y., Wang, Z., Zheng, Q., & Li, J. (2021). GREB1L overexpression correlates with prognosis and immune cell infiltration in lung adenocarcinoma. Science and Reports, 11, 13281. https://doi.org/10.1038/s41598-021-92695-x
doi: 10.1038/s41598-021-92695-x
Zhong, J., et al. (2016). Testis expressed 19 is a novel cancer-testis antigen expressed in bladder cancer. Tumour Biology, 37, 7757–7765. https://doi.org/10.1007/s13277-015-4567-8
doi: 10.1007/s13277-015-4567-8
pubmed: 26695143
Teng, M., Zhou, S., Cai, C., Lupien, M., & He, H. H. (2021). Pioneer of prostate cancer: Past, present and the future of FOXA1. Protein and Cell, 12, 29–38. https://doi.org/10.1007/s13238-020-00786-8
doi: 10.1007/s13238-020-00786-8
pubmed: 32946061
Dai, Y., et al. (2021). Expression of FOXA1 gene regulates the proliferation and invasion of human gastric cancer cells. Cellular and Molecular Biology, 67, 161–165. https://doi.org/10.14715/cmb/2021.67.2.25
doi: 10.14715/cmb/2021.67.2.25
pubmed: 34817322
Liu, J., et al. (2019). Circ-SERPINE2 promotes the development of gastric carcinoma by sponging miR-375 and modulating YWHAZ. Cell Proliferation, 52, e12648. https://doi.org/10.1111/cpr.12648
doi: 10.1111/cpr.12648
pubmed: 31199037
pmcid: 6668981